AnalystBook Research · Company Intelligence

FLOWSERVE CORP

FLSNYSE

Built from FLOWSERVE CORP's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Flowserve delivered steady growth, higher profit, margin and free cash flow across pumps, valves and aftermarket services.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue grew 3.8%OK
  • ProfitabilityNet income grew 22.5% to $346.247M from $282.759MOK
  • Cash flowFree cash flow grew 26.3% to $434.957M from $344.289MOK
  • MarginsOperating margin contracted 168 bps to 8.46%Watch
  • AccountingProfitable flow-control growthNote
  • Insiders2 purchases and 8 salesOK

Business

Flowserve manufactures pumps, valves, seals and related flow-control equipment.

Where the revenue comes from

Fiscal 2025, as FLOWSERVE CORP reports it. History and quarterly detail are in the app.

  • FPD$3.2B
  • FCD$1.5B

Leadership changes

From FLOWSERVE CORP's own filings, the day they're filed.

  • Matthew Klopfer · President · departureeff. 2026-04-11
  • Lamar Duhon · Chief Executive Officer · departureeff. 2026-04-11
  • Brian D. Savoy · Chief Financial Officer · appointmenteff. 2026-03-16

Latest filings

  • 8-K · Company announcement2026-08-05
  • 8-K · Company announcement2026-07-29
  • 10-Q · Quarterly report2026-07-29
  • 8-K · Company announcement2026-06-30
  • 8-K · Company announcement2026-05-28
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about FLOWSERVE CORP, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.